We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-3.05%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$17.8B
AUM Growth
+$1.43B
Cap. Flow
+$2.47B
Cap. Flow %
13.89%
Top 10 Hldgs %
2.97%
Holding
5,084
New
749
Increased
1,923
Reduced
1,590
Closed
686

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$70.4M
2
CHTR icon
Charter Communications
CHTR
+$62M
3
COST icon
Costco
COST
+$48.5M
4
CME icon
CME Group
CME
+$44.7M
5
KO icon
Coca-Cola
KO
+$36.8M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$55.4M
2
NFLX icon
Netflix
NFLX
+$48.9M
3
ADM icon
Archer Daniels Midland
ADM
+$41.4M
4
WDAY icon
Workday
WDAY
+$40.1M
5
NXPI icon
NXP Semiconductors
NXPI
+$39.4M

Sector Composition

Rank Sector Weight
1 Financials 14.69%
2 Technology 13.52%
3 Healthcare 9.74%
4 Consumer Discretionary 8.75%
5 Industrials 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSPD icon
4026
Lightspeed Commerce
LSPD
$1.36B
$97K ﹤0.01%
5,500
-144,279
-96% -$2.88M
ATRA icon
4027
Atara Biotherapeutics
ATRA
$77.6M
$96K ﹤0.01%
1,019
-9
-0.9% -$1.01K
EYPT icon
4028
EyePoint Inc
EYPT
$1.13B
$96K ﹤0.01%
12,152
+5,552
+84% +$51.6K
LRMR icon
4029
Larimar Therapeutics
LRMR
$417M
$96K ﹤0.01%
+30,055
New +$75.3K
SSP icon
4030
E.W. Scripps
SSP
$309M
$96K ﹤0.01%
8,535
-5,189
-38% -$73.5K
VIRX
4031
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$96K ﹤0.01%
22,371
+8,854
+66% +$37.5K
CVAC
4032
DELISTED
CureVac
CVAC
$94K ﹤0.01%
11,915
-146,605
-92% -$1.71M
SIG icon
4033
Signet Jewelers
SIG
$3.67B
$94K ﹤0.01%
1,644
-15,304
-90% -$922K
CROX icon
4034
Crocs
CROX
$6.63B
$93K ﹤0.01%
1,355
-29,659
-96% -$2.06M
VRM icon
4035
Vroom Inc
VRM
$51.2M
$93K ﹤0.01%
1,003
-2,389
-70% -$319K
SGI
4036
Somnigroup International
SGI
$13.6B
$93K ﹤0.01%
3,865
-223,919
-98% -$5.8M
HYFM icon
4037
Hydrofarm Holdings
HYFM
$9.29M
$92K ﹤0.01%
4,746
-1,916
-29% -$61.5K
LONA
4038
LeonaBio Inc
LONA
$70.5M
$91K ﹤0.01%
3,052
-956
-24% -$33K
MVST icon
4039
Microvast
MVST
$291M
$91K ﹤0.01%
+50,016
New +$120K
OSW icon
4040
OneSpaWorld
OSW
$2.62B
$91K ﹤0.01%
10,797
-7,049
-39% -$59.1K
AVPT icon
4041
AvePoint
AVPT
$2.75B
$90K ﹤0.01%
22,411
-41,766
-65% -$197K
CUE icon
4042
Cue Biopharma
CUE
$110M
$90K ﹤0.01%
1,346
-726
-35% -$62.5K
TDAY
4043
USA Today Co
TDAY
$1.05B
$90K ﹤0.01%
59,092
-37,293
-39% -$90.5K
CONN
4044
DELISTED
Conn's Inc.
CONN
$90K ﹤0.01%
12,757
-77,275
-86% -$735K
CPSS icon
4045
Consumer Portfolio Services
CPSS
$199M
$89K ﹤0.01%
12,269
-18,671
-60% -$214K
EHC icon
4046
Encompass Health
EHC
$12.4B
$89K ﹤0.01%
1,974
-126,995
-98% -$6.35M
HSY icon
4047
PUT
Hershey
HSY
$36.7B
$88K ﹤0.01%
+400
New +$89.6K
PRTY
4048
DELISTED
Party City Holdco Inc.
PRTY
$88K ﹤0.01%
+55,624
New +$93.4K
IMTX icon
4049
Immatics
IMTX
$1.33B
$87K ﹤0.01%
8,719
-2,092
-19% -$22.6K
MXCT icon
4050
MaxCyte
MXCT
$130M
$86K ﹤0.01%
13,258
+2,001
+18% +$11.2K

Similar funds

Cubist Systematic Strategies's Q3 2022 Portfolio in Review

As of Q3 2022, Cubist Systematic Strategies held 5,084 positions worth $17.8B, up 8.8% from $16.4B the previous quarter. Its ten largest holdings account for 3% of the portfolio.

Cubist Systematic Strategies deployed $2.47B of net new capital in Q3 2022, opening 749 new positions and adding to 1,923 existing holdings. Its largest new stake was Global Blockchain Acquisition Corp. Common Stock: 845,248 shares worth $8.34M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Bank of America, an estimated $55.4M trimmed.

  • Cubist Systematic Strategies's largest Q3 2022 buy was Global Blockchain Acquisition Corp. Common Stock: 845,248 shares worth $8.34M.
  • Cubist Systematic Strategies added most to Visa in Q3 2022, an estimated $70.4M increase.
  • Cubist Systematic Strategies's biggest Q3 2022 reduction was Bank of America, cutting an estimated $55.4M.
  • Cubist Systematic Strategies fully exited Bristol-Myers Squibb in Q3 2022, selling an estimated $24.2M.
  • Cubist Systematic Strategies's ten largest holdings make up 3% of its $17.8B portfolio in Q3 2022.
  • Cubist Systematic Strategies opened 749 new positions and closed 686 in Q3 2022.
  • Cubist Systematic Strategies's portfolio value rose 8.8% quarter-over-quarter to $17.8B.

Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.